0001724287-23-000002.txt : 20231218 0001724287-23-000002.hdr.sgml : 20231218 20231218162632 ACCESSION NUMBER: 0001724287-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 EFFECTIVENESS DATE: 20231218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bridge Therapeutics, Inc. CENTRAL INDEX KEY: 0001724287 ORGANIZATION NAME: IRS NUMBER: 473513057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500034 FILM NUMBER: 231494116 BUSINESS ADDRESS: STREET 1: 217 COUNTRY CLUB PARK, STE STREET 2: SUITE 325 CITY: BIRMINGHAM STATE: AL ZIP: 35213 BUSINESS PHONE: 800-223-6949 MAIL ADDRESS: STREET 1: 217 COUNTRY CLUB PARK, STE STREET 2: SUITE 325 CITY: BIRMINGHAM STATE: AL ZIP: 35213 D 1 primary_doc.xml X0708 D LIVE 0001724287 Bridge Therapeutics, Inc. 217 COUNTRY CLUB PARK, STE SUITE 325 BIRMINGHAM AL ALABAMA 35213 800-223-6949 DELAWARE None None Corporation true Timothy Grant Peara 18 Forest Road Asheville NC NORTH CAROLINA 28803-2908 Executive Officer James Gregory Sullivan 2100 Cameron Cir. Birmingham AL ALABAMA 35242 Executive Officer Director Elizabeth Kelley 2160 River Road Lucedale MS MISSISSIPPI 39452 Director Joseph Patrick Mullin 178 5th Ave, Apt. 6 New York NY NEW YORK 10010 Director Jason Bailey 2519 Shoreline Drive Keller TX TEXAS 76248 Director Christopher Palutis 397 Avawam Drive Richmond KY KENTUCKY 40475 Director Pharmaceuticals No Revenues 06c false 2023-10-27 false true true Optional conversion into equity at maturity false 2000 1500000 321000 1179000 false 22 0 0 N/A, the Company itself is offering the Note 0 false Bridge Therapeutics, Inc. Timothy G Peara Timothy G Peara President 2023-12-18